Is Kronos Bio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: KRON) stock is to Buy KRON stock.
Out of 1 analyst, 0 (0%) are recommending KRON as a Strong Buy, 1 (100%) are recommending KRON as a Buy, 0 (0%) are recommending KRON as a Hold, 0 (0%) are recommending KRON as a Sell, and 0 (0%) are recommending KRON as a Strong Sell.
What is KRON's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: KRON) forecast ROE is N/A, which is considered weak.
What is KRON's Price Target?
According to 1 Wall Street analyst that have issued a 1 year KRON price target, the average KRON price target is $10.00, with the highest KRON stock price forecast at $10.00 and the lowest KRON stock price forecast at $10.00.
The Wall Street analyst predicted that Kronos Bio's share price could reach $10.00 by Apr 17, 2024. The average Kronos Bio stock price prediction forecasts a potential upside of 536.94% from the current KRON share price of $1.57.
What is KRON's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: KRON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.